Publikationen (ausgewählte)

Bittner A., Ducray, A.D., Stoffel, M.H., Felser, A., Mevissen, M. (2019). Polymer-coated nanoparticles and their effects on mitochondrial function in brain endothelial cells. 2019. Toxicol Appl Pharmacol, 15(385Epub 2019 Nov 1.

von Niederhäusern, N., Ducray, A., Zielinski, J., Murbach, M., Mevissen, M. (2019). Effects of radiofrequency electromagnetic field exposure on neuronal differentiation and mitochondrial function in SH-SY5Y cells. Toxicol In Vitro, 61:104609. doi: 10.1016/j.tiv.2019.104609.

Bittner, A., Ducray, A.D., Widmer, H.R., Stoffel, M.H., Mevissen, M. 2019. Effects of gold and PCL- or PLLA-coated silica nanoparticles on brain endothelial cells and the blood-brain barrier. Beilstein J Nanotechnol, 25;10:941-954.

Tresch, M., Mevissen, M., Ayrle, H., Melzig, M., Roosje, P., Walkenhorst, M. (2019). Medicinal plants as therapeutic options for topical treatment in canine dermatology? A systematic review. BMC Vet Res, 15(1):174.

Vimercati, S., Elli, S., Jagannathan, V., Pandey, A.V., Peduto, N., Leeb, T., Mevissen, M. (2019). In silico and in vitro analysis of genetic variants of the equine CYP3A94, CYP3A95 and CYP3A97 isoenzymes. Toxicol In Vitro, 60:116-124.

Wiedmer, L., Ducray, A.D., Frenz, M., Stoffel, M.H., Widmer, H.R., Mevissen, M. (2019). Silica nanoparticle-exposure during neuronal differentiation modulates dopaminergic and cholinergic phenotypes in SH-SY5Y cells. J Nanobiotechnology, 17(1):46.

Schmitt, K., Lehner, C., Schuller, S., Schüpbach-Regula, G., Mevissen, M., Peter, R., Müntener, C.R., Naegeli, H., Willi, B. (2019). Antimicrobial use for selected diseases in cats in Switzerland. BMC Vet Res., 15(1):94.

Ayrle, H., Nathues, H., Bieber, A., Durrer, M., Quander, N., Mevissen, M., Walkenhorst, M. (2019). Placebo-controlled study on the effects of oral administration of Allium sativum L in postweaning piglets. Vet Rec., 184(10):316.

Kupper, J., Walkenhorst, M., Ayrle, H., Mevissen, M., Demuth, D., Naegeli, H. (2018). Online information system for phytotherapy in animals. SAT, 160(10):589-595.

Ayrle, H., Mevissen, M., Kaske, M., Vögtlin, A., Fricker, R., Hoffmann, B., Büttner, M., Marinovic, Z., Walkenhorst, M. (2018). Colostral transmission of BTV-8 antibodies from dairy cows six years after vaccination. Vaccine, 36(39):5807-5810.

Sandbaumhüter, F.A., Vimercati, S., Thormann, W., Mevissen, M. (2018). Role of the equine CYP3A94, CYP3A95 and CYP3A97 in ketamine metabolism in presence of medetomidine, diazepam and methadone studied by enantioselective capillary electrophoresis. Toxicol In Vitro. 50:242-248.

Peter, R., Demuth, D., Müntener, C., Lampart, M., Heim, D., Mevissen, M., Schüpbach-Regula, G., Schuller, S., Stucki, F., Willi, B., Burkhardt, W., Francey, T., Nett, C., Tschuor, F., Naegeli, H. (2017). AntibioticScout.ch: A decision supporting tool for antimicrobial stewardship: application to companion animal medicine. SAT, 159(10):525-533.

Ducray, A. D., Felser, A., Zielinski, J., Bittner, A., Burgi, J. V., Nuoffer, J. M., Frenz, M., & Mevissen, M. (2017). Effects of silica nanoparticle exposure on mitochondrial function during neuronal differentiation. J Nanobiotechnology, 15(1), 49.

Ducray, A. D., Stojiljkovic, A., Moller, A., Stoffel, M. H., Widmer, H. R., Frenz, M., & Mevissen, M. (2017). Uptake of silica nanoparticles in the brain and effects on neuronal differentiation using different in vitro models. Nanomedicine, 13(3), 1195-1204.

Peter, R., Demuth, D., Muntener, C., Lampart, M., Heim, D., Mevissen, M., Schupbach-Regula, G., Schuller, S., Stucki, F., Willi, B., Burkhardt, W., Francey, T., Nett, C., Tschuor, F., & Naegeli, H. (2017). AntibioticScout.ch: A decision supporting tool for antimicrobial stewardship: application to companion animal medicine. SAT, 159(10), 525-533.

Vimercati, S., Buchi, M., Zielinski, J., Peduto, N., & Mevissen, M. (2017). Testosterone metabolism of equine single CYPs of the 3A subfamily compared to the human CYP3A4. Toxicol In Vitro, 41, 83-91.

Parham, F., Portier, C. J., Chang, X., & Mevissen, M. (2016). The Use of Signal-Transduction and Metabolic Pathways to Predict Human Disease Targets from Electric and Magnetic Fields Using in vitro Data in Human Cell Lines. Front Public Health, 4, 193.

Zielinski, J., Moller, A. M., Frenz, M., & Mevissen, M. (2016). Evaluation of endocytosis of silica particles used in biodegradable implants in the brain. Nanomedicine, 12(6), 1603-1613.

Stojiljkovic, A., Kuehni-Boghenbor, K., Gaschen, V., Schupbach, G., Mevissen, M., Kinnear, C., Moller, A. M., & Stoffel, M. H. (2016). High-content analysis of factors affecting gold nanoparticle uptake by neuronal and microglial cells in culture. Nanoscale, 8(37), 16650-16661.

Peter, R., Muntener, C., Demuth, D., Heim, D., Mevissen, M., Schupbach-Regula, G., Schuller, S., Stucki, F., Willi, B., & Naegeli, H. (2016). AntibioticScout: Online tool for antimicrobial stewardship in veterinary medicine. Schweiz Arch Tierheilkd, 158(12), 805-810.

Ayrle, H., Mevissen, M., Kaske, M., Nathues, H., Gruetzner, N., Melzig, M., & Walkenhorst, M. (2016). Medicinal plants--prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review. BMC Vet Res, 12, 89.

Zielinski, J., & Mevissen, M. (2015). Inhibition of in vitro metabolism of testosterone in human, dog and horse liver microsomes to investigate species differences. Toxicol In Vitro, 29(3), 468-478.

Koch, F., Moller, A. M., Frenz, M., Pieles, U., Kuehni-Boghenbor, K., & Mevissen, M. (2014). An in vitro toxicity evaluation of gold-, PLLA- and PCL-coated silica nanoparticles in neuronal cells for nanoparticle-assisted laser-tissue soldering. Toxicol In Vitro, 28(5), 990-998.

Dettwiler, R., Schmitz, A. L., Plattet, P., Zielinski, J., & Mevissen, M. (2014). Heterologous expression of equine CYP3A94 and investigation of a tunable system to regulate co-expressed NADPH P450 oxidoreductase levels. PLoS One, 9(11), e113540.

Schmitz, A., Zielinski, J., Dick, B., & Mevissen, M. (2014). In vitro metabolism of testosterone in the horse liver and involvement of equine CYPs 3A89, 3A94 and 3A95. J Vet Pharmacol Ther, 37(4), 338-347.

Peters, L. M., Demmel, S., Pusch, G., Buters, J. T., Thormann, W., Zielinski, J., Leeb, T., Mevissen, M., & Schmitz, A. (2013). Equine cytochrome P450 2B6--genomic identification, expression and functional characterization with ketamine. Toxicol Appl Pharmacol, 266(1), 101-108.

Scinicariello, F., Buser, M. C., Mevissen, M., & Portier, C. J. (2013). Blood lead level association with lower body weight in NHANES 1999-2006. Toxicol Appl Pharmacol, 273(3), 516-523.

Stefanski, A., Mevissen, M., Moller, A. M., Kuehni-Boghenbor, K., & Schmitz, A. (2013). Induction of cytochrome P450 enzymes in primary equine hepatocyte culture. Toxicol In Vitro, 27(7), 2023-2030.